Disease management
The company's diagnostics platform helps predict how patients will respond to immunotherapy.
The company will use the funds to expand its commercial efforts and seek additional clinical validation of its tech-enabled offering.
More hospitals are coming into the fold in the coming months.
Also, Canon Medical and Olympus are collaborating on endoscopic ultrasonography.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
Also, researchers from India have developed an AI model that can detect indications of carpal tunnel syndrome in ultrasound videos.
The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis.
Employers aligned with Carrum can offer two years of treatment coverage to non-metastatic breast cancer patients via Florida Cancer Specialists & Research Institute.
The California-based company will use the funds to expand its Whole Body Twin Technology, aimed at preventing and reversing metabolic disease.